Trial NCT01307956

View at ClinicalTrials.gov 
Org. Study IDs: 0221-09-FB
Secondary IDs: NCI-2010-02056 P30CA036727

Last trial update was posted on 2023-10-26

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Calcium Calcium, Dietary Fluorouracil Folic Acid Immunoglobulins Leucovorin Levoleucovorin Oxaliplatin Panitumumab

MeSH Conditions

Adenocarcinoma Esophageal Neoplasms

Other Conditions

Adenocarcinoma of the Gastroesophageal Junction Esophageal Adenocarcinoma Stage IIA Esophageal Cancer Stage IIB Esophageal Cancer

Stopping Reasons

Drug manufacturer - Amgen requested study stop, per DSMB observation in POWER trial

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID